Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
1,472
datasets available to search
ShareScore release 0.9.0
Dataset results
1,472 results for “EGFR”
Anlotinib Versus Docetaxel as the Second-line Treatment in EGFR Wild Type Patients With Advanced NSCLC
ClinicalTrials.gov study NCT03703596. IPD Sharing: NO. Countries: 1. Publications: 0.
Assessing an Oral EGFR Inhibitor, DZD9008 in Patients With Advanced Non-small Cell Lung Cancer(NSCLC) With EGFR Mutations (WU-KONG15)
ClinicalTrials.gov study NCT05559645. IPD Sharing: NO. Countries: 1. Publications: 0.
Exploring the Mechanism of Primary Resistance to Third-generation EGFR-TKIs as First-line Treatment in EGFR-positive Advanced NSCLC (PRECISE Study)
ClinicalTrials.gov study NCT05598528. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Targeted Treatment With Intercalated Radiotherapy in EGFR-mutant IIIA/IIIB NSCLC
ClinicalTrials.gov study NCT03074864. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
A Study of Clinical Outcomes in Participants With EGFR Mutated Advanced Non-Small Cell Lung Cancer (NSCLC) in a Real-World Setting
ClinicalTrials.gov study NCT07230691. IPD Sharing: YES. Countries: 5. Publications: 0.
Study of NXP900 With Osimertinib in Subjects With Advanced, EGFR-Mutated Non-Small Cell Lung Cancer
ClinicalTrials.gov study NCT07315113. IPD Sharing: NO. Countries: 1. Publications: 0.
A Study of the Oral EGFR Inhibitor PLB1004 in Non-Small Cell Lung Cancer
ClinicalTrials.gov study NCT06046495. IPD Sharing: NO. Countries: 1. Publications: 0.
High-dose Furmonertinib Combined With Bevacizumab and Intrathecal Pemetrexed Chemotherapy in Patients With EGFR-mutated Non-small Cell Lung Cancer and Meningeal Metastasis
ClinicalTrials.gov study NCT06812871. IPD Sharing: NO. Countries: 1. Publications: 0.
First-line Furmonertinib in Advanced NSCLC Patients With EGFR Uncommon Mutation
ClinicalTrials.gov study NCT05548348. IPD Sharing: NO. Countries: 1. Publications: 0.
Effect of NK Cell Immunotherapy on Advanced Lung Adenocarcinoma Adenocarcinoma With EGFR Mutation
ClinicalTrials.gov study NCT03662477. IPD Sharing: YES. Countries: 1. Publications: 0.
GEfitinib Plus viNOrelbine in Advanced EGFR Mutated NSCLC. GENOA Trial
ClinicalTrials.gov study NCT02319577. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Safety and Efficacy of Combining APL-101 With Frontline Osimertinib in Patients With EGFR-mutated Metastatic Non-small Cell Lung Cancer (NSCLC)
ClinicalTrials.gov study NCT04743505. IPD Sharing: NO. Countries: 1. Publications: 0.
A Study of Amivantamab in Participants With Advanced or Metastatic Solid Tumors Including Epidermal Growth Factor Receptor (EGFR)-Mutated Non-Small Cell Lung Cancer
ClinicalTrials.gov study NCT05498428. IPD Sharing: YES. Countries: 12. Publications: 0.
Anlotinib Plus Sintilimab for NSCLC Patients With First-generation EGFR-TKIs Drug Resistance Along With T790M Negative
ClinicalTrials.gov study NCT03765775. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study to Evaluate the Efficacy and Safety of HLX07 in nsqNSCLC Patients With High EGFR Expression
ClinicalTrials.gov study NCT05215925. IPD Sharing: Not stated. Countries: 1. Publications: 0.
TKI Followed by Thoracic Radiotherapy for Stage IV EGFR Mutant NSCLC
ClinicalTrials.gov study NCT03916913. IPD Sharing: NO. Countries: 1. Publications: 0.
EGFR-mutated Lung Cancer in Randomized Investigator-Initiated Study
ClinicalTrials.gov study NCT06486142. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Phase Ib/II Study of Vebreltinib With Furmonertinib in NSCLC Patients With c-Met Amplification After EGFR-TKI Failure
ClinicalTrials.gov study NCT07087223. IPD Sharing: NO. Countries: 1. Publications: 0.
Pemetrexed Combined With Synchronous Gefitinib as Adjuvent Therapy in Patient With EGFR Mutant Lung Adenocarcinoma
ClinicalTrials.gov study NCT02518802. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Study of Osimertinib+Bevacizumab+Chemotherapy for EGFR+ Advanced Non-Small Cell Lung Cancer With Concurrent Mutations
ClinicalTrials.gov study NCT05507606. IPD Sharing: YES. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.